SP1 and cancer: The down-regulation of SP1 enhanced the sensitivity to anti-cancer drugs (Supplementary Figure 7A), the cleavage of FAK (Supplementary Figure 7B) and the caspase-3 activity (Supplementary Figure 7C) in response to anti-cancer drugs in Malme3MR cells.